GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediciNova Inc (TSE:4875) » Definitions » Cyclically Adjusted Book per Share

MediciNova (TSE:4875) Cyclically Adjusted Book per Share : 円254.90 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is MediciNova Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

MediciNova's adjusted book value per share for the three months ended in Mar. 2024 was 円182.759. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円254.90 for the trailing ten years ended in Mar. 2024.

During the past 12 months, MediciNova's average Cyclically Adjusted Book Growth Rate was 2.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 0.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -17.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of MediciNova was 6.20% per year. The lowest was -38.00% per year. And the median was -14.10% per year.

As of today (2024-05-27), MediciNova's current stock price is 円211.00. MediciNova's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was 円254.90. MediciNova's Cyclically Adjusted PB Ratio of today is 0.83.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of MediciNova was 3.72. The lowest was 0.15. And the median was 0.83.


MediciNova Cyclically Adjusted Book per Share Historical Data

The historical data trend for MediciNova's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediciNova Cyclically Adjusted Book per Share Chart

MediciNova Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 160.30 138.84 171.60 235.88 228.20

MediciNova Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 215.41 235.25 243.25 228.20 254.90

Competitive Comparison of MediciNova's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, MediciNova's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediciNova's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MediciNova's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where MediciNova's Cyclically Adjusted PB Ratio falls into.



MediciNova Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MediciNova's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=182.759/131.7762*131.7762
=182.759

Current CPI (Mar. 2024) = 131.7762.

MediciNova Quarterly Data

Book Value per Share CPI Adj_Book
201406 104.821 100.560 137.361
201409 102.119 100.428 133.995
201412 107.471 99.070 142.951
201503 102.344 99.621 135.378
201506 99.116 100.684 129.724
201509 138.868 100.392 182.281
201512 132.982 99.792 175.603
201603 137.100 100.470 179.819
201606 114.229 101.688 148.028
201609 105.499 101.861 136.483
201612 116.026 101.863 150.099
201703 107.066 102.862 137.162
201706 105.743 103.349 134.829
201709 107.819 104.136 136.437
201712 119.723 104.011 151.682
201803 194.849 105.290 243.865
201806 198.658 106.317 246.230
201809 196.866 106.507 243.574
201812 194.924 105.998 242.329
201903 193.676 107.251 237.965
201906 183.499 108.070 223.752
201909 184.027 108.329 223.858
201912 186.096 108.420 226.185
202003 179.195 108.902 216.835
202006 172.784 108.767 209.335
202009 172.865 109.815 207.435
202012 164.430 109.897 197.166
202103 205.884 111.754 242.770
202106 200.827 114.631 230.864
202109 194.315 115.734 221.249
202112 194.220 117.630 217.578
202203 194.305 121.301 211.085
202206 209.237 125.017 220.550
202209 213.573 125.227 224.743
202212 193.220 125.222 203.334
202303 184.572 127.348 190.990
202306 187.846 128.729 192.293
202309 194.938 129.860 197.815
202312 183.119 129.419 186.454
202403 182.759 131.776 182.759

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


MediciNova  (TSE:4875) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

MediciNova's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=211.00/254.9
=0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of MediciNova was 3.72. The lowest was 0.15. And the median was 0.83.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


MediciNova Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of MediciNova's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


MediciNova (TSE:4875) Business Description

Industry
Traded in Other Exchanges
Address
4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

MediciNova (TSE:4875) Headlines

No Headlines